Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

GenMark Diagnostics Inc. (NASDAQ:GNMK) said interim president and CEO Scott Mendel will now serve in those roles full-time. He joined the company as CFO in 2014 and became COO in 2019. The diagnostic company’s PCR-based SARS-CoV-2 test was granted Emergency Use Authorization

Read the full 421 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE